Literature DB >> 10708685

Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain.

R Duelli1, M H Maurer, R Staudt, S Heiland, L Duembgen, W Kuschinsky.   

Abstract

Whereas acute hyperglycemia has been shown to result in an unchanged local cerebral glucose utilization (LCGU) the changes of LCGU during chronic hyperglycemia are a matter of dispute. The present study had three aims: (1) To compare the effects of acute and chronic hyperglycemia on LCGU and to investigate in vivo the lactate level as a potential indicator of glycolytic flux. (2) To investigate local changes in brain Glut1 and/or Glut3 glucose transporter densities during chronic hyperglycemia. (3) To analyze the relationship between LCGU and local Glut densities during chronic hyperglycemia. To induce chronic hyperglycemia in rats steptozotocin was given i.p. and experiments were performed 3 weeks later. LCGU was measured by the 2-[14C]deoxyglucose method and intraparenchymal lactate concentration by MR-spectroscopy. Local densities of the glucose transport proteins were determined by immunoautoradiographic methods. During chronic hyperglycemia weighted average of LCGU increased by 13.9% whereas it remained unchanged during acute hyperglycemia. The cerebral lactate/choline ratio was increased by 143% during chronic hyperglycemia. The average density of glucose transporters Glut1 decreased by 7.5%. Local densities of Glut1 were decreased in 12 of 28 brain structures. Glut3 remained unchanged. Positive correlations were found between LCGU and local Glut densities during control conditions and during chronic hyperglycemia. It was concluded that (1) Chronic, but not acute hyperglycemia is followed by an increased LCGU. (2) The capacity to transport glucose is decreased during chronic hyperglycemia. (3) Increased LCGU and decreased densities of Glut1 are matched on a local level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708685     DOI: 10.1016/s0006-8993(00)01942-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

2.  Glucose administration after traumatic brain injury improves cerebral metabolism and reduces secondary neuronal injury.

Authors:  Nobuhiro Moro; Sima Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2013-08-29       Impact factor: 3.252

3.  Short-lived diabetes in the young-adult ZDF rat does not exacerbate neuronal Ca(2+) biomarkers of aging.

Authors:  Shaniya Maimaiti; Chris DeMoll; Katie L Anderson; Ryan B Griggs; Bradley K Taylor; Nada M Porter; Olivier Thibault
Journal:  Brain Res       Date:  2014-11-06       Impact factor: 3.252

4.  Recombinant FGF21 Protects Against Blood-Brain Barrier Leakage Through Nrf2 Upregulation in Type 2 Diabetes Mice.

Authors:  Zhanyang Yu; Li Lin; Yinghua Jiang; Ian Chin; Xiaojie Wang; Xiaokun Li; Eng H Lo; Xiaoying Wang
Journal:  Mol Neurobiol       Date:  2018-07-19       Impact factor: 5.590

5.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

6.  Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats.

Authors:  Tristano Pancani; Katie L Anderson; Lawrence D Brewer; Inga Kadish; Chris DeMoll; Philip W Landfield; Eric M Blalock; Nada M Porter; Olivier Thibault
Journal:  Neurobiol Aging       Date:  2013-03-29       Impact factor: 4.673

7.  Ovarian steroids influence cerebral glucose transporter expression in a region- and isoform-specific pattern.

Authors:  C S Harrell; J Burgado; S D Kelly; G N Neigh
Journal:  J Neuroendocrinol       Date:  2014-04       Impact factor: 3.627

8.  Tissue-dependent alterations in lipid mass in mice lacking glycerol kinase.

Authors:  Mikhail Y Golovko; Johnathan T Hovda; Zong-Jin Cai; William J Craigen; Eric J Murphy
Journal:  Lipids       Date:  2005-03       Impact factor: 1.880

9.  Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes--a 1H MRS study.

Authors:  Outi Heikkilä; Nina Lundbom; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Sari Mäkimattila
Journal:  Metab Brain Dis       Date:  2010-04-28       Impact factor: 3.584

Review 10.  Hippocampal calcium dysregulation at the nexus of diabetes and brain aging.

Authors:  Olivier Thibault; Katie L Anderson; Chris DeMoll; Lawrence D Brewer; Philip W Landfield; Nada M Porter
Journal:  Eur J Pharmacol       Date:  2013-07-17       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.